Co-Diagnostics, Inc.
CODX
$0.2981
-$0.002-0.67%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -11.62% | -22.34% | -71.09% | -91.70% | -94.70% |
| Total Other Revenue | -51.46% | -45.97% | 186.35% | -- | -- |
| Total Revenue | -47.63% | -42.53% | 57.16% | 25.24% | -44.91% |
| Cost of Revenue | -79.93% | -76.13% | 114.20% | 63.48% | 45.01% |
| Gross Profit | -1.78% | 11.00% | 23.37% | 8.24% | -70.69% |
| SG&A Expenses | -6.29% | -2.36% | -8.60% | -11.82% | 0.72% |
| Depreciation & Amortization | 6.59% | 11.93% | 9.61% | 3.72% | -7.87% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -15.74% | -11.15% | 2.27% | 2.86% | 14.27% |
| Operating Income | 10.79% | 6.15% | 3.88% | 1.31% | -37.14% |
| Income Before Tax | 9.07% | 1.39% | 28.54% | 24.92% | 1.45% |
| Income Tax Expenses | 109.41% | 102.07% | 139.99% | 118.09% | 94.00% |
| Earnings from Continuing Operations | 7.79% | -6.53% | 3.00% | 0.98% | -22.65% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 7.79% | -6.53% | 3.00% | 0.98% | -22.65% |
| EBIT | 10.79% | 6.15% | 3.88% | 1.31% | -37.14% |
| EBITDA | 11.31% | 6.68% | 4.29% | 1.47% | -39.17% |
| EPS Basic | 11.94% | -2.99% | 4.52% | 1.52% | -24.37% |
| Normalized Basic EPS | 14.24% | 8.68% | 6.32% | 2.11% | -41.46% |
| EPS Diluted | 11.59% | -2.52% | 4.87% | 2.08% | -24.20% |
| Normalized Diluted EPS | 14.24% | 8.68% | 6.32% | 2.11% | -41.46% |
| Average Basic Shares Outstanding | 4.91% | 3.35% | 2.05% | -0.57% | -4.16% |
| Average Diluted Shares Outstanding | 4.91% | 3.35% | 2.05% | -0.57% | -4.16% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |